stage 0 breast cancer

Release time ：Nov-11,2024

Ductal carcinoma in situ (DCIS), also referred to as stage 0 breast cancer, marks the earliest phase of the disease where malignant cells are confined to the milk ducts and have not invaded adjacent tissues or spread elsewhere. Patients at this stage typically exhibit no noticeable symptoms, and the condition is often identified unexpectedly during routine physicals or breast cancer screenings.

Treatment for stage 0 breast cancer is generally straightforward and associated with a favorable prognosis. The primary therapeutic approach involves surgical intervention, which can be either lumpectomy (breast-conserving surgery) or mastectomy, based on the individual patient's circumstances. Chemotherapy and radiation therapy are usually not indicated as the cancer cells have not yet breached the duct walls. However, for certain high-risk cases, such as those that are HER2-positive or hormone receptor-positive, adjuvant therapy might be recommended to mitigate the risk of recurrence.

Early detection and prompt treatment are paramount for patients with stage 0 breast cancer. Women are advised to conduct regular self-breast exams and to adhere to their physicians' recommendations for periodic breast cancer screenings. Upon diagnosis, it is imperative to seek specialized treatment promptly, while also maintaining a positive mindset and actively engaging with the treatment plan prescribed by their healthcare provider.